| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2567584 | Pulmonary Pharmacology & Therapeutics | 2008 | 7 Pages |
Abstract
In spite of a lack of power, our results suggest that FP has a beneficial effect on symptoms and Mk on blood eosinophil level as compared to placebo. Except for a difference in one lung function parameter after 3 months between FP and Mk in favor of the FP group, this study revealed no differences between FP and Mk.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Elisabeth M.W. Kooi, Siebrig Schokker, H. Marike Boezen, Tjalling W. de Vries, Anja A.P.H. Vaessen-Verberne, Thys van der Molen, Eric J. Duiverman,